NCT06992310

Brief Summary

A methodical evaluation of sound changing principles in CE-labelled Sonova brand hearing instruments (e.g. Phonak hearing instruments) is intended to be conducted on hearing impaired participants. These sound changing principles are enabled by respective hearing instrument technologies and hearing instrument algorithms. The aim of the study is to investigate and asses strength and weaknesses of these novel sound changing principles in terms of hearing performance to determine their application in hearing instruments (Phase of development). Objective laboratory measurements as well as subjective ratings will be carried out. This will be a controlled, single blinded and randomized active comparator clinical evaluation which will be conducted mono centric at Sonova AG Headquarter based in Stäfa.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2025

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 28, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

1 month

First QC Date

May 27, 2025

Last Update Submit

May 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Own Voice Level

    Changes to the participants' own voice level (RMS in dB) during a conversation in noise in the laboratory will be recorded in each interventional condition.

    3 weeks

Secondary Outcomes (2)

  • Interpersonal distance

    3 weeks

  • Qualitative interview form

    3 weeks

Study Arms (3)

Hearing aid standard NR_1

ACTIVE COMPARATOR

Hearing Aid with standard noise reduction (NR) serves as reference condition

Device: Hearing Aid with standard noise reduction (NR_1)

Hearing Aid with NR_2

EXPERIMENTAL

NR\_2: Noise reduction principle 2

Device: Hearing Aid with NR_2

Hearing Aid with NR_3

EXPERIMENTAL

NR\_3: Noise reduction principle 3

Device: Hearing Aid with NR_3

Interventions

Each participant will be fitted with the 3 different noise reduction (sound changing) principles on the same hearing aid, saved to 3 manual programs (ensures exact same hearing loss compensation for each intervention). Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The active comparator condition is the state of the art Noise Reduction principle to mimic the natural directivity of the outer ear.

Hearing aid standard NR_1

Each participant will be fitted with the 3 different noise reduction (sound changing) principles on the same hearing aid, saved to 3 manual programs (ensures exact same hearing loss compensation for each intervention). Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.

Hearing Aid with NR_2

Each participant will be fitted with the 3 different noise reduction (sound changing) principles on the same hearing aid, saved to 3 manual programs (ensures exact same hearing loss compensation for each intervention). Noise Reduction principle is a sound processing algorithm to remove noise from a speech signal to improve the speech intelligibility and comfort. The experimental conditions vary in their parametrization to result in different degrees of noise suppression and good speech quality.

Hearing Aid with NR_3

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Good written and spoken German language skills
  • No suffering from any speech disorders
  • Experienced hearing aid user (min. 6 months)
  • Ability to stand and walk during the experiment
  • Ability to fill in a questionnaire conscientiously
  • Ability to produce a reliable hearing test result
  • Ability to describe listening experiences/impressions
  • The audiogram is in the fitting range of the hearing aid
  • The audiogram is in the range of mild to moderate hearing losses (N2 - N4)
  • Hearing loss in both ears
  • Informed consent form

You may not qualify if:

  • Contraindications to the medical device
  • Unaidable hearing loss in one or both ears
  • Acute tinnitus (in either one ear and occurrence for less than 3 months)
  • Anatomical deformity of one or both ears
  • Single-sided deafness
  • Unwillingness to wear the investigational device during the investigational visits
  • Active pacemaker implant
  • Ear canals are too narrow to take ear impressions
  • Ear canals are too narrow for the use of customized earpieces
  • Uncomfortable loudness threshold less than 80 dB for at least one measured frequency
  • Known hypersensitivity or allergy against synthetic materials
  • Acute symptoms of vertigo or dizziness
  • Reported Parkinson's disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sonova AG

Stäfa, 8712, Switzerland

Location

MeSH Terms

Conditions

Hearing Loss

Interventions

Hearing Aids

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesSensory Aids

Study Officials

  • Josephine Hollenbach

    Sonova AG

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sebastian Griepentrog

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each participant will be treated with each sound changing principle in a randomized order.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical studies manager

Study Record Dates

First Submitted

May 27, 2025

First Posted

May 28, 2025

Study Start

August 1, 2025

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

June 3, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations